APA (7th ed.) Citation

K, P., M, G., E, Ż., K, S., A, S., K, N., . . . H, M. (2018). HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling. Frontiers in pharmacology, 9, 1146. https://doi.org/10.3389/fphar.2018.01146

Chicago Style (17th ed.) Citation

K, Pytka, et al. "HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling." Frontiers in Pharmacology 9 (2018): 1146. https://doi.org/10.3389/fphar.2018.01146.

MLA (9th ed.) Citation

K, Pytka, et al. "HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin Signaling." Frontiers in Pharmacology, vol. 9, 2018, p. 1146, https://doi.org/10.3389/fphar.2018.01146.